Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis

Nephron - Clinical Practice

Volumn 102, Issue 1, 2006, Pages

  Ito Ihara, Toshiko ^a   Ono, Takahiko ^a   Nogaki, Fumiaki ^a   Suyama, Katsuo ^a   Tanaka, Mari ^b   Yonemoto, Satomi ^b   Fukatsu, Atsushi ^a   Kita, Toru ^a   Suzuki, Kazuo ^c   Muso, Eri ^b  

^a KYOTO UNIVERSITY   (Japan)

^b Kitano Hospital   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Intravenous immunoglobulin; MPO ANCA; Tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; KENKETSU GLOVININ I; KENKETSU VENILON I; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARM EDEMA; ARTICLE; BORDERLINE HYPERTENSION; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE ACTIVITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTIOUS COMPLICATION; LEG EDEMA; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REMISSION; SCORING SYSTEM; SEROLOGY; SYSTEMIC DISEASE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; C-REACTIVE PROTEIN; CREATINE; CYCLOPHOSPHAMIDE; CYTOKINES; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULONEPHRITIS; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PEROXIDASE; PREDNISOLONE; REMISSION INDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 32844456754     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088313     Document Type: Article

References (23)

1. Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;i:425-429.
2. Cunningham MA, Ono T, Hewitson TD, Tipping PG, Becker GJ, Holdsworth SR: Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis. Kidney Int 1999;55:1311-1318.
3. Harper L, Savage CO: ANCA-associated renal vasculitis at the end of the twentieth century - a disease of older patients. Rheumatology (Oxford) 2005;44:495-501.
4. Jayne DR, Davies MJ, Fox CJ, Black CM, Lockwood CM: Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991;337:1137-1139.
5. Jayne DR, Chapel H, Adu D, Misbah S, O'Donoghue D, Scott D, Lockwood CM: Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 2000;93:433-439.
6. Kazatchkine MD, Kaveri SV: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001;345:747-755.
7. Sharief MK, Ingram DA, Swash M, Thompson EJ: Intravenous immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome. Neurology 1999;52:1833-1838.
8. Jayne DR, Lockwood CM: Intravenous immunoglobulin as sole therapy for systemic vasculitis. Br J Rheumatol 1996;35:1150-1153.
9. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192.
10. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-678.
11. Yashiro M, Muso E, Itoh-Ihara T, Oyama A, Hashimoto K, Kawamura T, Ono T, Sasayama S: Significantly high regional morbidity of MPO-ANCA-related angiitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan). Am J Kidney Dis 2000;35:889-895.
12. Sakai H, Kurokawa K, Koyama A, Shiiki H, Nishi S, Mitarai T, Yokoyama H, Yoshimura A, Yorioka N: Guidelines for the management of rapidly progressive glomerulonephritis. Nippon Jinzo Gakkai Shi 2002;44:55-82.
13. Tsujimoto H, Takeshita S, Nakatani K, Kawamura Y, Tokutomi T, Sekine I: Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease. Clin Immunol 2002;103:161-168.
14. Harper L, Ren Y, Savill J, Adu D, Savage CO: Antineutrophil cytoplasmic antibodies induce reactive oxygen-dependent dysregulation of primed neutrophil apoptosis and clearance by macrophages. Am J Pathol 2000;157:211-220.
15. Arimura Y, Minoshima S, Kamiya Y, Tanaka U, Nakabayashi K, Kitamoto K, Nagasawa T, Sasaki T, Suzuki K: Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis. Clin Nephrol 1993;40:256-264.
16. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R: In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 1993;43:682-692.
17. Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-4119.
18. Savage CO, Pottinger BE, Gaskin G, Pusey CD, Pearson JD: Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992;141:335-342.
19. Booth A, Harper L, Hammad T, Bacon P, Griffith M, Levy J, Savage C, Pusey C, Jayne D: Prospective study of TNF-α blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 2004;15:717-721.
20. Kaveri S, Vassilev T, Hurez V, Lengagne R, Lefranc C, Cot S, Pouletty P, Glotz D, Kazatchkine MD: Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use. J Clin Invest 1996;97:865-869.
21. Spahn JD, Leung DY, Chan MT, Szefler SJ, Gelfand EW: Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin. J Allergy Clin Immunol 1999;103:421-426.
22. Cayco AV, Perazella MA, Hayslett JP: Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature. J Am Soc Nephrol 1997;8:1788-1794.
23. Girbes AR: Prevention of acute renal failure: role of vasoactive drugs, mannitol and diuretics. Int J Artif Organs 2004;27:1049-1053.